Literature DB >> 9491851

Molecular mechanisms controlling human melanoma progression and metastasis.

D R Welch1, S F Goldberg.   

Abstract

Progression from normal melanocyte to metastatic melanoma is a multistep, multigenic process. While relatively easy to conceptualize, the stages of melanoma progression are not necessarily discrete, nor are they unambiguously defined at the morphologic or molecular levels. The ability to stage the lesions more precisely would afford clinicians a greater confidence when designing therapeutic strategies. Unfortunately, a molecular definition of cells at each stage does not yet exist. Toward that end, the purpose of this review is twofold: (1) to highlight recent advances in our understanding of the molecular genetics of human cutaneous melanoma predisposition, and (2) to construct a molecular model of melanoma progression toward metastasis.

Entities:  

Mesh:

Year:  1997        PMID: 9491851     DOI: 10.1159/000164143

Source DB:  PubMed          Journal:  Pathobiology        ISSN: 1015-2008            Impact factor:   4.342


  12 in total

1.  Liver metastatic ability of human melanoma cell line is associated with losses of chromosomes 4, 9p21-pter and 10p.

Authors:  Z Adám; R Adány; A Ladányi; J Tímár; M Balázs
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

2.  Epigenetic PTEN silencing in malignant melanomas without PTEN mutation.

Authors:  X P Zhou; O Gimm; H Hampel; T Niemann; M J Walker; C Eng
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

3.  Variability in melanoma metalloproteinase expression profiling.

Authors:  Orsi Giricz; Janelle L Lauer; Gregg B Fields
Journal:  J Biomol Tech       Date:  2010-12

Review 4.  The KISS1 metastasis suppressor: mechanistic insights and clinical utility.

Authors:  Kevin T Nash; Danny R Welch
Journal:  Front Biosci       Date:  2006-01-01

Review 5.  Chromosomal aberrations related to metastasis of human solid tumors.

Authors:  Lun-Xiu Qin
Journal:  World J Gastroenterol       Date:  2002-10       Impact factor: 5.742

6.  Metastasis-suppressed C8161 melanoma cells arrest in lung but fail to proliferate.

Authors:  S F Goldberg; J F Harms; K Quon; D R Welch
Journal:  Clin Exp Metastasis       Date:  1999       Impact factor: 5.150

7.  Prognostic significance of BRMS1 expression in human melanoma and its role in tumor angiogenesis.

Authors:  J Li; Y Cheng; D Tai; M Martinka; D R Welch; G Li
Journal:  Oncogene       Date:  2010-10-11       Impact factor: 9.867

8.  Primary cutaneous melanoma: an 18-year study.

Authors:  Moris Anger; Henri Friedhofer; Marina Fussae Fukutaki; Marcus Castro Ferreira; Gilles Landman
Journal:  Clinics (Sao Paulo)       Date:  2010-03       Impact factor: 2.365

9.  In vitro loss of heterozygosity targets the PTEN/MMAC1 gene in melanoma.

Authors:  G P Robertson; F B Furnari; M E Miele; M J Glendening; D R Welch; J W Fountain; T G Lugo; H J Huang; W K Cavenee
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

10.  CXCL12/CXCR4 axis plays pivotal roles in the organ-specific metastasis of pancreatic adenocarcinoma: A clinical study.

Authors:  Weixia Zhong; Weiwei Chen; Dexian Zhang; Jujie Sun; Yuhui Li; Jianbo Zhang; Yongsheng Gao; Wuyuan Zhou; Sheng Li
Journal:  Exp Ther Med       Date:  2012-07-04       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.